Skip to main content

Pharma Companies HR contact information

Dear viewers of my blog, I am happy to share the HR contact details of Pharmaceutical companies.

Contact Details Of Pharma HRs :

Zaydus cadila-Goa
gajendravernekar@zayduscadila.com
09623458512/08326615143

Teva-Goa
Maryann.Braganza@teva.co.in
sanjay.pandit@teva.co.in
0832 6685538

Glenmark-Goa
Vittal hebbalkar hr executivr - 9923476869
anupbannatti@glenmark-generics.com
09604151586

Watson-Goa
Jyosna.bagule@watsonpharm.co.in
runa.divkar@watsonpharm.co.in
goa@watsonpharm.co.in
0832 6690666/777

Unichem Labs-Goa
abhiram.panshikar@unichemlabs.com
R&D 
suraj.jadhav@unichemlabs.com
vikas.parkar@unichemlabs.com

Indico-Goa
goahplc@Indoco.com
varun.keny@indoco.com
anand.ingole@Indoco.com
0832 6624109

Encube-Goa
hr@encubeethicals.com
nidhi.b@encubeethicals.com
8322392223

Torrent pharma-Ahmdabad
mayurdesai@torrentpharma.com
9879603921/22/23/24

Emcure-pune
RPKulkarni@emcure.co.in          
Kishor.Mule@emcure.co.in
Rahul.Morgaonkar@emcure.co.in
recruitment@emcure.co.in
hr.plantIII@emcure.co.in
Dastgir.Mujawar@emcure.co.in
02039821300

Centaur-Pune
hrpune@centaur.co.in
mpatil@centaur.co.in
020 66739460/00

Sandoz-Mumbai
satheesh.nair@sandoz.com
022 27639065

Flamingo-Mumbai
hr@flamingopharma.com
saloni.samani@flamingopharma.com
9324067298

Ajanta-Mumbai
Hareshwar.warude@ajantapharma.com
Inventiahealthcare-Mumbai
dharmendra.rajbhar@inventiahealthcare.com
022 6716 3452 / 3688

Lupin-Bhoisar
trhr@lupinpharma.com, dileepnair@lupinpharma.com

Ajanta Aurangabad
sridhar.tedulapu@ajantapharma.com
venkata.rao@ajantapharma.com
girish.shinde@ajantapharma.com
Nirmalplacement.hr@gmail.com
7385119561/ 02431664000

Wockhardt-Aurangabad
jwaghmode@wockhardt.com
eouhr@wockhardt.com
0240 6626455

Maylan-Aurangabad
sawti.thorat@Mylan.in
8888847799

Glenmark-Aurangabad
sanjaykulkarni@glenmarkpharma.com

Alembic Pharma
mansi.meheta@alembic.co.in

Hospira India, Vishkhapatnam
Suseela.Ruttala@hospira.com
mahesh.bv@hospira.com
0891 306642

Comments

Post a Comment

Popular posts from this blog

DoE - Doctrine of Equivalents

The Doctrine of Equivalents is a legal principle that is relevant to patent law, particularly in the United States, and it helps protect inventors' rights even when minor changes or substitutions have been made to a patented invention.  When an inventor applies for a patent, the claims in the patent document define the scope of protection for the invention. These claims outline the specific elements or features of the invention that are considered unique and non-obvious. If another party copies or uses the patented invention without permission, it may be considered infringement. However, in some cases, the accused infringer may make slight modifications to the invention that fall outside the literal scope of the patented claims. The Doctrine of Equivalents comes into play here. It allows the patent holder to assert that the accused infringer's modified version is still equivalent to the patented invention and, therefore, falls within the scope of the patent protection. For the

Competitive Landscape for Pharmaceutical Generic products.

Creating a competitive landscape for a pharmaceutical generic product involves analyzing the market and identifying key players, their strengths, weaknesses, and market positioning. Here's a simplified outline: **Competitive Landscape Analysis for Pharmaceutical Generic Product:** 1. **Market Overview:**    - Size of the pharmaceutical generic product market.    - Growth trends and forecasts.    - Regulatory environment and barriers to entry. 2. **Key Players:**    - List the major pharmaceutical companies producing the generic product.    - Include both global and regional players. 3. **Market Share:**    - Percentage of market share held by each major player.    - Trends in market share changes over time. 4. **Product Portfolio:**    - Types of generic products offered by each player.    - Variations in strengths, dosage forms, and delivery methods. 5. ** Competitive Advantage :**    - Identify unique selling points of each player's products.    - Cost advantages, manufacturi